From protein structure and folding with Chirascan, to reaction kinetics with the SX20, and stability screening with SUPR-DSF, our tools support confident biologics development from discovery to QC.
Biologics US
2nd - 3rd October 2025
Join Nicoya and Applied Photophysics at Biologics US!
Biologics US 2025 brings together leaders in biologics R&D through two focused programs on one dynamic platform. Over two immersive days, the event spotlights breakthrough innovations in proteins, antibodies, and the development of antibody-drug conjugates (ADCs).
Attendees will delve into the latest advances in biologics & ADC's research, therapeutic optimization, and ADC manufacturing strategies. With collaboration at its core, Biologics US fosters meaningful partnerships, cross-disciplinary alignment, and actionable insights—empowering the community to transform novel science into life-changing treatments for patients.
Join Nicoya and Applied Photophysics at Booth 11 to explore how technologies like circular dichroism, stopped-flow kinetics, protein stability screening, and SPR are empowering smarter biologics development from discovery through to QC.
2025 Highlights
Proteins & Antibodies
- Discuss The Challenges Of Identifying & Validating New, Difficult Targets Including Strategies To Find Antigens With Low Expression Or Intracellular Localization Using Proteomics, Transcriptomics, And AI Prediction.
- Gain Insights In Applications Of AI/ML To Predict Antibody Solubility, Expression, Aggregation, And Immunogenicity Early In The Pipeline.
- Learn About Computational Advances In Protein Engineering Utilizing Machine Learning, Molecular Dynamics, And Predictive Modeling To Refine Antibody Structures, Predict Mutations, And Reduce Immunogenicity.
- Tap Into The Latest Research In Multi-Specific Immune Cell Engagers Including Talks On Molecules Designed To Bind Immune Cells (E.G., T Cells, NK Cells) And Tumor Antigens Simultaneously To Drive Targeted Cell Killing.
ADC Discovery & Development
- Explore Strategies For Streamlining ADC Product Development Including Integration Of Platform Approaches, Automation, And Parallel Processing To Accelerate Drug Development Timelines And Reduce Costs.
- Ascertain How To Maximize The Efficacy Of ADCs Through Strategies Like Optimizing Internalization Rates, Targeting Rapidly Dividing Cells, And Improving Payload Potency To Increase Therapeutic Impact.
- Tap Into Strategies To Optimise The Design Of ADCs Focusing On Balancing Efficacy And Safety By Refining Antibody Selection, Drug-To-Antibody Ratio (DAR), Conjugation Chemistry, And Payload Potency.
- Establish Shortened ADC Manufacturing Timelines By Leveraging Continuous Manufacturing, Modular Facilities, And Rapid Analytical Techniques To Meet Urgent Clinical Demands And Faster Go-To-Market Timeline
Our Products
